![]() |
JOURNAL TOOLS |
Opzioni di pubblicazione |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |
Share |

I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
REVIEW Free access
Italian Journal of Dermatology and Venereology 2025 April;160(2):123-44
DOI: 10.23736/S2784-8671.25.08001-6
Copyright © 2025 EDIZIONI MINERVA MEDICA
lingua: Inglese
Head and neck dermatitis: a variant of atopic dermatitis
Leszek BLICHARZ, Agnieszka MICHALCZYK, Małgorzata MAJ, Joanna CZUWARA ✉, Małgorzata OLSZEWSKA, Lidia RUDNICKA
Department of Dermatology, Medical University of Warsaw, Warsaw, Poland
Atopic dermatitis involves the head and neck area across all age groups. This manifestation is frequently referred to as “the head and neck dermatitis.” Aside from a considerable deterioration of the quality of life, it poses a significant diagnostic and therapeutic challenge. The head and neck dermatitis may be mimicked by other inflammatory conditions such as seborrheic dermatitis or contact dermatitis. Furthermore, it can be associated with a wide range of infectious, ocular, psychiatric and hair disorders, which should raise clinical alertness and encourage a multidisciplinary management of the affected individuals. Skin lesions in the head and neck area are often difficult to treat, particularly because of a considerable exposure of this region to exacerbating factors and limitations regarding the use of some pharmaceuticals. Although several hypotheses explaining the recalcitrant course of head and neck dermatitis have been proposed, none of them provide successful solutions applicable in the daily clinical practice. This comprehensive review comprises the current insights on the pathogenesis, clinical presentation, and comorbidities of the head and neck dermatitis. Recommendations regarding possible treatments of this condition such as antifungals, as well as special considerations for the choice of biologics or JAK inhibitors in the candidates for systemic treatment are outlined.
KEY WORDS: Allergy; Dermatitis, atopic; Biological products; Malassezia; Janus kinase inhibitors